PMV Pharmaceuticals (PMVP) Other Non Operating Income (2019 - 2026)

PMV Pharmaceuticals (PMVP) has 8 years of Other Non Operating Income data on file, last reported at $981000.0 in Q1 2026.

• Quarterly Other Non Operating Income rose 24625.0% year-over-year to $981000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$994000.0 (up 88.15% YoY) and the FY2025 annual result came in at -$45000.0, down 181.25% from the prior year.
• Other Non Operating Income improved to $981000.0 in Q1 2026, from -$5.1 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $3.1 million in Q4 2023 to a low of -$8.5 million in Q4 2024.
• A 5-year average of $110647.1 and a median of $573000.0 in 2022 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 438.69% — and 2026, when it jumped 24625.0%.
• Tracing PMVP's Other Non Operating Income over 5 years: stood at -$1.8 million in 2022, then soared by 273.76% to $3.1 million in 2023, then tumbled by 369.86% to -$8.5 million in 2024, then jumped by 39.84% to -$5.1 million in 2025, then soared by 119.21% to $981000.0 in 2026.
• The last three Other Non Operating Income figures came in at $981000.0 (Q1 2026), -$5.1 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.